Azenta, Inc. (AZTA) revenue by segment
AZTANasdaqSpecial Industry Machinery, NECFiscal year ends September 30
Số liệu tài chính tới Q4 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-K on Nov 19, 2026Score 9/3011% below fair value
$48.69+2.88 (+6.29%)
Close on Nov 18, 2026Market cap $2.13BP/E –Yield –
Doanh thu theo bộ phận của Azenta, Inc.
Periods
Theo bộ phận kinh doanh
| Doanh thu | FY2025CY2025 | FY2024CY2024 | FY2023CY2023 | FY2022CY2022 | FY2021CY2021 | FY2020CY2020 | FY2019CY2019 | FY2018CY2018 | FY2017CY2017 | FY2016CY2016 | % doanh thu | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sample Management Solutions | $324.59M | $318.90M | $303.19M | $304.56M | – | – | – | – | – | – | 54.7% | +1.8% |
| Multiomics | $269.23M | $254.55M | $248.30M | $250.94M | – | – | – | – | – | – | 45.3% | +5.8% |
| Core Products | $197.63M | $196.50M | $192.06M | $199.23M | – | – | – | – | – | – | 33.3% | +0.6% |
| Sample Repository Services | $126.96M | $122.39M | $111.13M | $105.33M | – | – | – | – | – | – | 21.4% | +3.7% |
| B Medical Systems S.a.r.l. | – | $83.13M | $113.12M | $0 | – | – | – | – | – | – | – | – |
| Life Sciences Products | – | – | $305.18M | $199.23M | $199.61M | $129.76M | $119.02M | – | – | – | – | – |
| Life Sciences Services | – | – | $359.89M | $356.27M | $314.10M | $258.78M | $215.16M | – | – | – | – | – |
| Brooks Semiconductor Solutions Group | – | – | – | – | – | $508.74M | $446.67M | $435.02M | $378.79M | $325.90M | – | – |
| Brooks Life Sciences Products | – | – | – | – | – | $129.76M | $119.02M | $106.15M | – | – | – | – |
| Brooks Life Sciences Services | – | – | – | – | – | $258.78M | $215.16M | $90.40M | – | – | – | – |
| Brooks Life Sciences | – | – | – | – | – | – | $334.18M | $196.54M | $148.71M | $108.11M | – | – |
| Brooks Life Science Systems | – | – | – | – | – | – | – | – | $148.71M | $108.11M | – | – |
| Operating Segments | – | – | – | – | – | – | – | – | – | $560.32M | – | – |
| Lợi nhuận hoạt động | FY2025CY2025 | FY2024CY2024 | FY2023CY2023 | FY2022CY2022 | FY2021CY2021 | FY2020CY2020 | FY2019CY2019 | FY2018CY2018 | FY2017CY2017 | FY2016CY2016 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sample Management Solutions | $27.55M | $11.11M | -$2.29M | $23.97M | – | – | – | – | – | – | +148.1% |
| Multiomics | -$11.94M | -$7.73M | -$13.34M | $5.03M | – | – | – | – | – | – | +54.4% |
| B Medical Systems S.a.r.l. | – | -$5.67M | $919.00K | $0 | – | – | – | – | – | – | – |
| Life Sciences Products | – | – | -$30.32M | $11.03M | $23.09M | -$3.04M | -$20.88M | – | – | – | – |
| Life Sciences Services | – | – | -$14.72M | $10.78M | $22.66M | $2.86M | $8.98M | – | – | – | – |
| Brooks Semiconductor Solutions Group | – | – | – | – | – | $82.95M | $69.96M | $62.51M | $42.74M | $16.63M | – |
| Brooks Life Sciences Products | – | – | – | – | – | $9.35M | -$1.84M | -$9.04M | – | – | – |
| Brooks Life Sciences Services | – | – | – | – | – | $28.83M | $22.47M | $12.84M | – | – | – |
| Brooks Life Sciences | – | – | – | – | – | – | $20.63M | $3.80M | $3.22M | -$6.45M | – |
| Brooks Life Science Systems | – | – | – | – | – | – | – | – | $4.70M | -$6.45M | – |
| Operating Segments | – | – | – | – | – | – | – | – | – | $31.48M | – |
Theo sản phẩm hoặc dịch vụ
| Doanh thu | FY2025CY2025 | FY2024CY2024 | FY2023CY2023 | FY2022CY2022 | FY2021CY2021 | FY2020CY2020 | FY2019CY2019 | FY2018CY2018 | FY2017CY2017 | FY2016CY2016 | % doanh thu | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Services | $420.63M | $399.73M | $375.39M | $374.55M | $332.67M | $277.97M | $233.74M | $149.17M | $120.51M | – | 70.8% | +5.2% |
| Products | $173.19M | $173.72M | $176.10M | $180.95M | $181.04M | $110.57M | $100.44M | $482.39M | $406.99M | – | 29.2% | -0.3% |
Theo khu vực
| Doanh thu | FY2025CY2025 | FY2024CY2024 | FY2023CY2023 | FY2022CY2022 | FY2021CY2021 | FY2020CY2020 | FY2019CY2019 | FY2018CY2018 | FY2017CY2017 | FY2016CY2016 | % doanh thu | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $365.00M | $365.05M | $351.41M | $358.21M | $320.80M | $253.50M | $224.50M | $232.70M | $172.90M | $156.90M | 61.5% | -0.0% |
| Rest of Europe | $107.37M | $95.15M | $87.19M | $79.01M | $77.27M | $74.16M | $59.98M | $135.61M | $59.96M | $49.13M | 18.1% | +12.8% |
| China | $58.35M | $58.24M | $52.13M | $53.87M | $45.74M | $34.02M | – | – | – | – | 9.8% | +0.2% |
| United Kingdom | $35.39M | $27.20M | $26.66M | $30.26M | $31.54M | – | $48.76M | $51.69M | $37.28M | $31.34M | 6.0% | +30.1% |
| Asia Pacific | $23.28M | $21.32M | $25.63M | $32.83M | – | – | – | $262.71M | $255.83M | $196.12M | 3.9% | +9.2% |
| Other | $4.43M | $6.47M | $8.47M | – | – | – | – | – | – | – | 0.7% | -31.5% |
| Africa | – | $61.96M | $65.09M | $1.33M | $688.00K | – | – | – | – | – | – | – |
| North America | – | – | $359.42M | $361.11M | $323.98M | $256.17M | $226.40M | $233.24M | $174.43M | $157.43M | – | – |
| Asia / Pacific / Other | – | – | $52.16M | $29.93M | $34.49M | $24.19M | – | – | – | – | – | – |
| Asia Pacific and Other | – | – | – | – | $80.92M | $58.21M | $47.80M | $262.71M | $255.83M | – | – | – |
Lấy từ thuyết minh bộ phận và phân tách doanh thu trong hồ sơ 10-K, 10-Q của Azenta (XBRL). Số quý 4 bằng cả năm tài chính trừ chín tháng đầu. Tên bộ phận giữ theo cách công ty tự đặt và có thể đổi khi công ty tái cấu trúc. Tab KPI hiện các bộ phận này cạnh chỉ số vận hành của Azenta, kèm đầy đủ lịch sử, biểu đồ và liên kết tới từng hồ sơ.
Chỉ số vận hành
| Remaining performance obligations (RPO) | FY2025CY2025 | FY2024CY2024 | FY2023CY2023 | FY2022CY2022 | FY2021CY2021 | FY2020CY2020 | FY2019CY2019 | YoY |
|---|---|---|---|---|---|---|---|---|
| Remaining performance obligations (RPO) | $66.89M | $121.71M | $78.39M | $80.20M | $50.47M | $62.12M | $28.42M | -45.0% |
Các số lượng và quy mô Azenta gắn thẻ trong thuyết minh hồ sơ 10-K, 10-Q (XBRL), tính đến cuối mỗi kỳ. Phần phân tách giữ theo cách công ty tự đặt tên; mỗi chỉ số hiện tối đa 15 dòng.
See a number that looks wrong?